GOETTINGEN, Germany & AUBAGNE, France & PARIS--(BUSINESS WIRE)--The combination of the Biotechnology Division of the German company Sartorius AG (FWB:SRT) and French-based Stedim S.A. has been wrapped up. Today, on Friday, June 29, 2007, Sartorius AG acquired the share package from the Stedim founders. At the extra-ordinary general meeting that took place afterwards in Paris, Stedim shareholders approved the contribution of the carved-out Biotechnology Division from Sartorius into Stedim and thus the increase in capital this entailed. Therefore, Sartorius AG is the majority shareholder with a controlling stake in the new company.
